Uçkaya Gökhan, Karadurmuş Nuri, Kutlu Onur, Corakçi Ahmet, Kizildağ Sefa, Ural Ali Uğur, Gül Davut, Kutlu Mustafa
Department of Endocrinology and Metabolism, Gulhane School of Medicine, Etlik, Ankara, Turkey.
Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S135-40. doi: 10.1016/j.diabres.2008.09.022. Epub 2008 Oct 28.
We have determined 11-beta-Hydroxysteroid Dehydrogenase Type 1 (HSD11B1) and Hexose-6-Phosphate Dehydrogenase (H6PD) mRNA expression levels in adipose tissues from patients with type 2 diabetes mellitus.
Six non-diabetic and seven diabetic male patients who undergo elective abdominal surgery were included in the study and visceral and subcutaneous adipose tissue samples were obtained. Fresh preadipocyte cultures were administered to low and high glucose medium (11M and 25M) in vitro for 24h and mRNA extractions were performed. HSD11B1 and H6PD gene mRNA expression levels were determined by real-time PCR and compared. Glyceraldehyde-3-phosphate Dehydrogenase (G3PD) mRNA level is used as housekeeping gene expression.
HSD11B1 mRNA levels were significantly higher in patient with T2DM than controls in both visceral and subcutaneous adipose tissues (3.35+/-0.7 vs. 0.37+/-0.1; P=0.01 and 2.07+/-0.8 vs. 0.11+/-0.05; P=0.01, respectively). H6PD mRNA levels were also significantly higher in patient with T2DM than controls in both visceral and subcutaneous adipose tissues (3.95+/-1.2 vs. 1.95+/-0.8; P=0.050 and 2.23+/-1.1 vs. 0.46+/-0.1; P=0.043, respectively).
Failure to down-regulate HSD11B1 activity in patients with type 2 diabetes may contribute to the pathogenesis of T2DM. Subcutaneous and visceral adipose tissues similarly exhibit the same variation in patients with type 2 diabetes mellitus.
我们测定了2型糖尿病患者脂肪组织中11-β-羟基类固醇脱氢酶1型(HSD11B1)和6-磷酸己糖脱氢酶(H6PD)的mRNA表达水平。
本研究纳入了6名接受择期腹部手术的非糖尿病男性患者和7名糖尿病男性患者,并获取了内脏和皮下脂肪组织样本。将新鲜的前脂肪细胞培养物在体外分别置于低糖和高糖培养基(11M和25M)中培养24小时,然后进行mRNA提取。通过实时PCR测定并比较HSD11B1和H6PD基因的mRNA表达水平。以甘油醛-3-磷酸脱氢酶(G3PD)的mRNA水平作为看家基因表达。
在2型糖尿病患者中,内脏和皮下脂肪组织中HSD11B1的mRNA水平均显著高于对照组(分别为3.35±0.7对0.37±0.1;P = 0.01和2.07±0.8对0.11±0.05;P = 0.01)。2型糖尿病患者内脏和皮下脂肪组织中H6PD的mRNA水平也显著高于对照组(分别为3.95±1.2对1.95±0.8;P = 0.050和2.23±1.1对0.46±0.1;P = 0.043)。
2型糖尿病患者未能下调HSD11B1活性可能有助于2型糖尿病的发病机制。皮下和内脏脂肪组织在2型糖尿病患者中同样表现出相同变化。